Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

BioCorRx (BICX) Retained Earnings (2016 - 2025)

BioCorRx's Retained Earnings history spans 16 years, with the latest figure at -$87.2 million for Q3 2025.

  • For Q3 2025, Retained Earnings fell 6.29% year-over-year to -$87.2 million; the TTM value through Sep 2025 reached -$87.2 million, down 6.29%, while the annual FY2024 figure was -$83.2 million, 6.54% down from the prior year.
  • Retained Earnings for Q3 2025 was -$87.2 million at BioCorRx, down from -$85.3 million in the prior quarter.
  • Across five years, Retained Earnings topped out at -$66.3 million in Q1 2021 and bottomed at -$87.2 million in Q3 2025.
  • The 5-year median for Retained Earnings is -$76.3 million (2023), against an average of -$76.4 million.
  • The largest annual shift saw Retained Earnings tumbled 3339.7% in 2021 before it fell 5.07% in 2023.
  • A 5-year view of Retained Earnings shows it stood at -$70.0 million in 2021, then dropped by 6.24% to -$74.3 million in 2022, then fell by 5.07% to -$78.1 million in 2023, then fell by 6.54% to -$83.2 million in 2024, then fell by 4.8% to -$87.2 million in 2025.
  • Per Business Quant, the three most recent readings for BICX's Retained Earnings are -$87.2 million (Q3 2025), -$85.3 million (Q2 2025), and -$84.1 million (Q1 2025).